15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.

Aurigene Discovery Technologies
Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors.

Aurigene Discovery Technologies
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.

Aurigene Discovery Technologies
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors.

Aurigene Discovery Technologies
Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild type and mutant (L1196M) active compounds with unique binding mode.

Aurigene Discovery Technologies
Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors.

Aurigene Discovery Technologies
Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.

Aurigene Discovery Technologies
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.

Aurigene Discovery Technologies
Pyrrolo[1,2-b] pyridazine derivatives

Gilead Sciences
Compounds useful as RET inhibitors

Cancer Research Technology
5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

Temple University
Adrenergic receptor modulating compounds and methods of using the same

The Leland Stanford Junior University
Therapeutic compounds and uses thereof

Genentech
Compositions for APP-selective BACE inhibition and uses therefor

University of California
Alkynyl pyridine prolyl hydroxylase inhibitor, and preparation method and medical use thereof

Jiangsu Hengrui Medicine